1 of 1
Story summary
- Galderma Group is acquiring U.S. skincare brand ZO Skin Health for $1.5 billion.
- The all-cash purchase will be funded with existing cash reserves and bank financing.
- Closing is expected in Q4 2026 or early 2027, pending regulatory approval.
- Sellers include Blackstone Tactical Opportunities and the family of founder dermatologist Zein Obagi.
- Galderma projects a neutral impact on adjusted core EPS in the first full fiscal year.